$10.40
0.393.9%
Last update: Nov 6, 4:00 PM
The average analyst price target for Vicore Pharma Holding is $20, 99.2% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $15 to $25. The latest change came on Nov 4, 2026, when Chardan Capital initiated coverage of Vicore Pharma Holding with a Buy rating and a $15 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
